−1,510 KRW
−19.10 B KRW
17.06 B KRW
12.58 M
About OLIX PHARMACEUTICALS, INC.
Sector
CEO
Dong-Gi Lee
Headquarters
Suwon-si
Website
Founded
2010
ISIN
KR7226950004
FIGI
BBG00L3G26X2
OliX Pharmaceuticals, Inc. engages in the research and development of treatments and the manufacture and sale of new drugs. It develops acid-based therapeutics based on ribonucleic acid interference (RNAi) technology. It offers hypertrophic scar treatments, subretinal fibrosis treatments, rod-cone dystrophy treatments, age-related macular degeneration products, and others. The company was founded by Dong-Ki Lee on February 26, 2010 and is headquartered in Suwon-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 226950 is 16,490 KRW — it has decreased by −11.11% in the past 24 hours. Watch OLIX PHARMACEUTICALS, INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange OLIX PHARMACEUTICALS, INC. stocks are traded under the ticker 226950.
226950 stock has fallen by −33.51% compared to the previous week, the month change is a −14.56% fall, over the last year OLIX PHARMACEUTICALS, INC. has showed a 19.75% increase.
226950 reached its all-time high on Dec 3, 2020 with the price of 61,000 KRW, and its all-time low was 8,280 KRW and was reached on Jun 24, 2024. View more price dynamics on 226950 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
226950 stock is 14.64% volatile and has beta coefficient of −0.20. Track OLIX PHARMACEUTICALS, INC. stock price on the chart and check out the list of the most volatile stocks — is OLIX PHARMACEUTICALS, INC. there?
Today OLIX PHARMACEUTICALS, INC. has the market capitalization of 284.26 B, it has decreased by −18.02% over the last week.
Yes, you can track OLIX PHARMACEUTICALS, INC. financials in yearly and quarterly reports right on TradingView.
226950 net income for the last quarter is −10.51 B KRW, while the quarter before that showed −9.58 B KRW of net income which accounts for −9.62% change. Track more OLIX PHARMACEUTICALS, INC. financial stats to get the full picture.
No, 226950 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 74.00 employees. See our rating of the largest employees — is OLIX PHARMACEUTICALS, INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OLIX PHARMACEUTICALS, INC. EBITDA is −18.41 B KRW, and current EBITDA margin is −91.09%. See more stats in OLIX PHARMACEUTICALS, INC. financial statements.
Like other stocks, 226950 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OLIX PHARMACEUTICALS, INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OLIX PHARMACEUTICALS, INC. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OLIX PHARMACEUTICALS, INC. stock shows the sell signal. See more of OLIX PHARMACEUTICALS, INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.